COMMUNIQUÉS West-GlobeNewswire

Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

02/05/2025 - 22:30

WALTHAM, Mass., May 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with [...]

Result of General Meeting

02/05/2025 - 22:30

May 2, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Result of General Meeting Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative [...]

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02/05/2025 - 22:42

VANCOUVER, British Columbia and BOSTON, May 02, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering [...]

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02/05/2025 - 23:00

BOSTON, May 02, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous [...]

Adial Pharmaceuticals Announces a Warrant Inducement Transaction for $2.75 Million in Gross Proceeds

02/05/2025 - 17:48

GLEN ALLEN, Va., May 02, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“ Adial ” or the “ Company ”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment [...]

Trial Finds Inquis Medical’s AVENTUS Thrombectomy System Safe and Effective for Patients with Pulmonary Embolism

02/05/2025 - 17:50

Results of AVENTUS IDE Trial presented at SCAI Scientific Sessions MENLO PARK, Calif. and WASHINGTON, May 02, 2025 (GLOBE NEWSWIRE) -- Inquis Medical , a leading innovator in venous thromboembolic disease treatment, [...]

CARBIOS annonce la mise à disposition de son Document d’enregistrement universel 2024

02/05/2025 - 18:00

Clermont-Ferrand (France), le 2 mai 2025 (18h00 CEST). CARBIOS, (Euronext Growth Paris : ALCRB), pionnière dans le développement et l'industrialisation de technologies biologiques pour réinventer le cycle de vie des [...]

CARBIOS files its 2024 Universal Registration Document

02/05/2025 - 18:00

Clermont-Ferrand (France), May 2, 2025 (6:00 pm CEST). CARBIOS , (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and [...]

Sanofi: Informations relatives au nombre de droits de vote et d'actions – Mars 2025

02/05/2025 - 18:00

Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]

Sanofi: Information concerning the total number of voting rights and shares - March 2025

02/05/2025 - 18:00

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]

The Best SARMS for Cutting, Muscle Growth, Strength & Recovery - User Guide to Buying SARM Stacks for Bulking Cycles, Fat Loss & Shredding - CrazyBulk

02/05/2025 - 18:46

New York City, May 02, 2025 (GLOBE NEWSWIRE) -- There are around 10-12 SARMs commonly used in bodybuilding, each tailored to specific goals like bulking, cutting, or boosting strength and recovery. Many bodybuilders [...]

Best Probiotics For Vaginal Health: Top Probiotics To Treat Bacterial Vaginosis [BV] & pH Balance – WOLFSON BRANDS (UK) LIMITED

02/05/2025 - 19:05

Looking for the best probiotics for vaginal health? Try YourBiology – clinically proven to support vaginal flora, fight bacterial vaginosis, and promote feminine wellness naturally. Glasgow, May 02, 2025 (GLOBE NEWSWIRE [...]

Best Probiotics For Gut Health: Top Probiotic Supplements To Relieve IBS, Diarrhea & Constipation – Wolfson Brands (UK) Limited

02/05/2025 - 19:31

Looking for the best probiotics for gut health? Discover how YourBiology Gut+ supports digestion, reduces bloating, and helps ease IBS symptoms like diarrhea and constipation. Glasgow, May 02, 2025 (GLOBE NEWSWIRE) -- [...]

Java Burn Reviews (Complaints & Side Effects) 2025 Update: Verified Users Reveal Does Java Burn Coffee Work?

02/05/2025 - 19:59

New York, May 02, 2025 (GLOBE NEWSWIRE) -- If you're looking for the answer to shedding a few pounds without a radical diet revolution, you have probably already come across Java Burn. Java Burn is a natural coffee [...]

ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference

02/05/2025 - 14:00

LEIDEN, Netherlands & CAMBRIDGE, Mass., May 02, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its [...]

Vaxart to Host First Quarter 2025 Business Update and Financial Results Conference Call on May 13

02/05/2025 - 14:00

Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a business update and report financial results for the [...]

Pacira BioSciences to Present New Data on Clinical Immunogenicity of Intra-Articular PCRX-201 and Its Implications for Dosing Strategy in Knee Osteoarthritis

02/05/2025 - 14:00

Data will be featured at the ASGCT 28th Annual Meeting BRISBANE, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to deliver innovative, non-opioid [...]

ALX Oncology to Report First Quarter 2025 Financial Results on May 8, 2025

02/05/2025 - 14:00

SOUTH SAN FRANCISCO, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies [...]

ARS Pharmaceuticals Announces Co-Promotion Agreement with Partner and Global Allergy Leader ALK-Abelló A/S to Expand Reach of neffy® (epinephrine nasal spray) to Additional U.S. Pediatricians

02/05/2025 - 14:00

Agreement builds on landmark licensing deal between ARS Pharma and ALK-Abelló A/S, which provided ARS Pharma with $145 million upfront and ALK with commercialization rights to neffy in Canada, United Kingdom, European [...]